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Reactive oxygen species (ROS) are inevitably generated, due to the incomplete re-
duction of O2 in electron transfer reactions, as byproducts of biological reactions. When
ROS production is greater than the detoxification capacity of the cell, excessively genera-
ted ROS causes extensive damage to DNA, proteins and lipids and acts as a mediator of
pro-inflammatory and carcinogenic events (1). To avoid redox imbalance and oxidative
damage, aerobic organisms possess efficient biochemical defense systems such as super-
oxide dismutase (SOD), catalase (CAT) and glutathione peroxidase (GPx) (2), though it can-
not completely protect them from severe oxidative stress. In this context, many scientists
have tried to obtain dietary antioxidants such as ascorbate, tocopherol and carotenoids
from fruits and vegetables, because they could help protect cells from cellular damage
caused by oxidative stress.
Several experimental animal models of hepatotoxicity have been developed to in-
vestigate the toxicological mechanisms between environmental contaminants and liver.
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Ethanolic extract (50 %) of stems of Calotropis gigantea R.
Br. (Asclepiadaceae) at doses of 250 and 500 mg kg–1 were
studied for hepatoprotective activity in male Wistar rats
with liver damage induced using carbon tetrachloride, 2
mL kg–1 twice a week. The protective effect of C. gigantea
extract was compared with the standard drug silymarin.
Various biochemical parameters such as aspartate amino
transferase (AST), alanine amino transferase (ALT), gluta-
thione (GSH), lipid peroxide (LPO), superoxidedismutase
(SOD), glutathione peroxidase (GPx) and catalase (CAT)
were evaluated. The results revealed that the C. gigantea
extract significantly decreased AST, ALT (p < 0.001) and
lipid peroxide (p < 0.01) levels. The antioxidant parame-
ters GSH, GPx, SOD and catalase levels were increased
considerably compared to their levels in groups not trea-
ted with C. gigantea extract.
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Thus, the animal model of acute liver injury induced by carbon tetrachloride (CCl4) has
been utilized to screen hepatoprotective compounds (3), because trichloromethyl free ra-
dicals (CCl3) as metabolites of CCl4 initiate a lipid peroxidation process in cellular mem-
branes, eventually leading to various liver pathological processes, such as fibrogenesis,
cirrhosis or steatosis (4).
Calotropis gigantea R. Br. (Asclepiadaceae), a wildly growing plant, has been reported
to possess a number of medicinal properties and is used in toothache and earache, sprain,
anxiety, pain, epilepsy and in mental disorders (5). Aerial parts of the plant have been
reported to possess anti-diarrheal properties (6) and flowers are known for their analge-
sic activity (7). The roots of the plant have shown CNS activity (5) as well as pregnancy
interceptive properties (8).
The stem bark of C. gigantea yields resin and wax. The wax contains b-amyrin and
its isovalerate, a and b-calotropeols, mixture of tetracyclic triterpene, traces of sterols,
C31 and C33 hydrocarbons, fatty acids and giganteol. The stem of C. gigantea yields latex.
The latex contains cardiac glycosides, calotropin, uscharin, calotoxin, uscharidin and gi-
gantin. The proteolytic enzyme calotropain has been isolated from the latex. Calotropain
has marked anti-blood coagulating activity. The latex consists of calotropin DI and DII
and calotropain FI and FII and an enzyme with invertase activity. It is a promising anti-
-inflammatory agent (9).
Phytochemical investigations of the leaves of C. gigantea have shown the presence
of taraxasterly acetate, pinoresinol, medioresinol, uzarigenin, calotropin, calactin, cala-
citnic acid, calacitnic acid methyl ester, 19-carboxyl-calacitnic methyl ester, drummon-
dol, 15b-hydroxycalotrin, the C11 bicylic lactone norisopenoid, the rare diphenyl furfu-
ran lignan, salicifoliol and 19-nor- and 18,20-epoxy-cardenolides (10).
The aim of the present study is to evaluate the hepatoprotective activity of the 50 %
ethanolic extract of Calotropis gigantea stems and to compare its efficacy with silymarin.
EXPERIMENTAL
Plant material
The stems of Calotropis gigantea (Asclepiadaceae) were procured locally from Lucknow
district of Uttar Pradesh in India and were identified at the Hygia Institute of Pharma-
ceutical Education and Research, Lucknow (India). Voucher specimens are kept in the
herbarium (HIPER/07/12) of the Institute for further references.
Stems were washed with tap water, chopped into pieces and dried in shade. Dried
stem pieces were ground to coarse powder and stored in an airtight container. The dried
stems were extracted (250 g) with ethyl alcohol (50 %, V/V) in a Soxhlet extractor for
18–20 h. The extract was concentrated to dryness under reduced pressure and controlled
temperature (40–50 °C).
The extract thus obtained was preserved in a desiccator to prevent degradation by
moisture. For pharmacological studies, the C. gigantea extract was suspended in doubly
distilled water containing carboxymethyl cellulose (1 %, m/V, CMC). Preliminary phyto-
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chemical screening was carried out on the C. gigantea extract to assess the presence of al-
kaloids, glycosides, saponins, flavanoids and steroids.
Drugs and chemicals
All the drugs and chemicals used in the study were of analytical grade. Carbon tet-
rachloride was obtained from Merck Limited, India. Silymarin was obtained from Ran-
baxy Laboratories Limited, India. The chemicals used for evaluation of oxidative stress
parameters were obtained from Sisco Research Laboratories, India. Kits used for the esti-
mation of serum aspartate and alanine transaminase (AST and ALT) levels were pur-
chased from Centronic GmbH, Germany. Folin-Ciocalteu reagent was purchased from
Sigma Chemicals (USA).
Determination of total phenolics
One hundred milligrams of the C. gigantea extract was dissolved in 250 mL of meth-
anol/water (60:40, V/V, 0.3 % HCl) and filtered through a 0.45-µm Millipore filter. To 100 mL
of filtrate, 100 mL of Folin-Ciocalteu reagent (50 %, V/V) and 2.0 mL of sodium carbonate
(2 %, m/V) were added and mixed completely. After 2 hours, the absorbance of the solu-
tion was measured at 750 nm. Quantification was based on the standard curve of gallic
acid (0–1.0 mg mL–1) dissolved in methanol/water (60:40, V/V, 0.3 % HCl). Phenolic con-
tent was expressed as milligrams per gram of gallic acid equivalent (GAE).
Experimental animals
Studies were carried out using male Wistar albino rats (180–220 g). They were ob-
tained from the animal house of the Hygia Institute of Pharmaceutical Education and
Research, Lucknow, India. The animals were grouped and housed in polyacrylic cages
(38 ´ 23 ´ 10 cm) with not more than six animals per cage and maintained under stan-
dard laboratory conditions (temperature 25 ± 2 °C) with light and dark cycles of 12 and
12 h, respectively. They were allowed free access to the standard dry pellet diet and wa-
ter ad libitum. All procedures described were reviewed and approved by the Institutional
Animal Ethical Committee.
Hepatoprotective study
The rats were divided into five groups of six animals each. Group I, normal control,
was given 1 mL normal saline orally once daily. Groups II through V received subcuta-
neous injections of CCl4 in olive oil (1:1) at a dose of 2 mL kg–1 twice a week to induce
hepatotoxicity. Group II served as CCl4 control. Groups III and IV received C. gigantea
extract at doses of 250 and 500 mg kg–1. Group V received silymarin at a dose of 100 mg
kg–1. In the treatment groups, C. gigantea extract and silymarin were administered orally
once daily, starting 2 h before the CCl4 injection. After 1 week of treatment, the rats were
sacrificed, blood was collected and serum was separated.
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Biochemical analyses
The AST and ALT levels in the serum were estimated using commercially available
kits.
The reduced glutathione (GSH) level in the liver was determined according to the
method of Ellman (11); hepatic superoxide dismutase (SOD) activity by the method of
Kakkar et al. (12), glutathione peroxidase (GPx) by the method of Paglia and Valentine
(13) and catalase by the method of Aebi (14).
The hepatic TBARS level, an index of malonyldialdehyde (MDA) production, was
determined by the method of Ohkawa et al. (15).
Histopathological analysis of liver
For histological studies, liver tissues were fixed with 10 % phosphate-buffered neu-
tral formalin, dehydrated in graded (50–100 %) alcohol and embedded in paraffin. Thin
sections were cut and stained with hematoxylin and eosin stain for microscopic assess-
ment. The initial examination was qualitative, with the purpose of determining histo-
pathological lesions in liver tissue.
Statistical analysis
The values are expressed as mean ± SEM of six observations. The results obtained
were statistically analyzed by Student’s t-test.
RESULTS AND DISCUSSION
The preliminary phytochemical screening of C. gigantea extract indicated the pres-
ence of triterpenoids, steroids, flavonoids and glycosides. The extract was found to con-
tain 330.0 ± 13.6 mg g–1 total polyphenolics expressed as GAE (milligrams per gram of
GAE).
The effect of C. gigantea extract on AST and ALT levels in rats with CCl4 induced
hepatotoxicity is summarized in Figure 1. There was a significant (p < 0.001) increase in
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Fig. 1. Effect of C. gigantea on serum
AST and ALT levels in rats with CCl4-
-induced hepatotoxicity. Values repre-
sent mean ± SEM of six animals in
each group (a p < 0.001 vs. group II).
the AST and ALT levels in rats treated with CCl4 alone compared to normal control. The
AST levels significantly (p < 0.001) increased to 317.00 U L–1 in CCl4-treated rats and
was considerably reduced on treatment with C. gigantea extract at doses of 250 mg kg–1
(263.17 U L–1, p < 0.001) and 500 mg kg–1 (210.19 U L–1, p < 0.001). The ALT levels of the
rats treated with CCl4 were found to be increased (181.13 U L–1) and there was a signifi-
cant (p < 0.001) reduction to 137.2 U L–1 and 103.13 U L–1 by C. gigantea extract at 250 mg
kg–1 and 500 mg kg–1 dose respectively. The AST and ALT levels were significantly (p <
0.001) reduced to 171.33 and 66.81 UL–1, repectively, by administration of silymarin at a
100 mg kg–1 dose.
The effects of C. gigantea extract on GSH, TBARS, SOD, GPx and catalase in rats with
CCl4-induced hepatotoxicity are summarized in Table I. For example, there was a mar-
ked decrease in GSH level in rats treated with CCl4, i.e. 2.63 mg g–1 as compared to 7.51
mg g–1 (p < 0.001) in normal control rats. The GSH level was significantly increased to
3.71 (p < 0.01), 4.15 (p < 0.001) and 5.37 (p < 0.001) by the treatment with C. gigantea ex-
tract at 250 mg kg–1, 500 mg kg–1 and silymarin at 100 mg kg–1 doses, respectively. The
data obtained in the present study (Table I) clearly shows an increase in the MDA levels
of rats treated with CCl4 suggesting enhanced lipid peroxidation leading to tissue dam-
age and failure of antioxidant defense mechanisms to prevent formation of excessive
free radicals. The increase in TBARS levels (37.13 mmol g–1 compared to 8.83 mmol g–1
in normal control) was significantly reduced by the treatment with C. gigantea extract at
doses of 250 mg kg–1 (31.11 mmol g–1, p < 0.01), 500 mg kg–1 (26.11 mmol g–1, p < 0.001)
and by the treatment with silymarin at dose of 100 mg kg–1 (7.78 mmol g–1, p < 0.001).
The SOD levels in normal control rats were 148.11 U mg protein–1 which was re-
duced to 69.23 U mg protein–1 in rats treated with CCl4. The level of SOD was increased
again to 77.12 U mg protein–1 and 108.43 U mg protein–1 (p < 0.001) by the administra-
tion of C. gigantea extract at dose of 250 mg kg–1 and 500 mg kg–1, respectively. Silymarin
at 100 mg kg–1 dose increased the SOD levels to 120.37 U mg protein–1 (p < 0.001).
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Group I 7.51 ± 0.17b 8.83 ± 0.67b 148.11 ± 0.61b 51.14 ± 5.13b 5.18 ± 0.38b
Group II 2.63 ± 0.27a,b 37.13 ± 0.88a,b 69.23 ± 5.91b 20.11 ± 1.71a,b 2.91 ± 0.13a,b
Group III 3.71 ± 0.24a 31.11 ± 2.16a 77.12 ± 2.79 27.91 ± 2.97a 3.11 ± 0.21
Group IV 4.15 ± 0.16b 26.11 ± 1.59b 108.43 ± 3.91b 32.93 ± 0.98b 4.63 ± 0.37a
Group V 5.37 ± 0.18b 7.78 ± 0.58b 120.37 ± 6.95b 47.72 ± 0.56b 4.97 ± 0.11b
Values represent mean ± SEM of six animals in each group.
Group I – normal control, group II – CCl4 (2 mL kg–1) twice a week, group III – C. gigantea extract (250 mg
kg–1) + CCl4 (2 mL kg–1) twice a week, group IV – C. gigantea extract (500 mg kg–1) + CCl4 (2 mL kg–1) twice a
week, group V – silymarin (100 mg kg–1) + CCl4 (2 mL kg–1) twice a week.
Significant difference between groups I, III–V and group II: a p < 0.01, b p < 0.001.
The level of GPx in rats treated with CCl4 was 20.11 U mg protein–1 (a reduction
from 31.03 U mg protein–1 compared to normal control). The levels of GPx increased again
to 27.91 (p < 0.01) and 32.93 (p < 0.001) U mg protein–1 in rats treated with C. gigantea ex-
tract of 250 mg kg–1 and 500 mg kg–1, respectively. Silymarin produced a significant
(p < 0.001) increase to 47.72 U mg protein–1 in GPx levels at 100 mg kg–1 dose.
Administration of C. gigantea extract increased the CAT level in CCl4 treated rats
with induced liver damage, thus preventing accumulation of excessive free radicals and
protecting the liver from CCl4 intoxication (Table 1). The level of catalase (2.91 U mg
protein–1) was significantly increased by the administration of C. gigantea extract (500
mg kg–1 to 4.63 U mg protein–1 (p < 0.01) and by silymarin (100 mg kg–1) to a 4.97 U mg
protein–1 value (p < 0.001).
Histological observations basically supported the results obtained from serum en-
zyme assays. The liver of CCl4-intoxicated rats showed massive fatty changes, gross ne-
crosis and broad infiltration of lymphocytes and Kupffer cells around the central vein
and loss of cellular boundaries. Histopathological observations of the liver of rats pre-
treated with C. gigantea extract and subsequently given CCl4 showed a more or less nor-
mal architecture of the liver, having reversed to a large extent the hepatic lesions pro-
duced by the toxin, almost comparable to the normal control and the silymarin group
(Figs. 2a-d).
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Fig. 2. Section of the liver of a) normal control rat, b) a rat treated with carbon tetrachloride, c) a rat
treated with C. gigantea extract (500 mg kg–1) + CCl4 (2 mL kg–1) twice a week, d) a rat treated with
silymarin (100 mg kg–1) + CCl4 (2 mL kg
–1) twice a week.
CONCLUSIONS
Based on the results obtained, it may be concluded that the Calotropis gigantea stem
extract has a significant effect on liver injuries as well as on oxidative stress, resulting in
reduced lipid peroxidation and improved serum biochemical parameters such as AST
and ALT. The reduced levels of parameters of SOD, CAT, GSH and GPx in CCl4-treated
rats were significantly increased by treatment with C. gigantea extract.
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S A @ E T A K
Hepatoprotektivno djelovanje ekstrakta biljke Calotropis gigantea na o{te}enje
jetre {takora tetraklormetanom
GAURAV LODHI, HEMANT KUMAR SINGH, KAMLESH K. PANT i ZEASHAN HUSSAIN
Etanolni ekstrakt (50 %) stabljika biljke Calotropis gigantea R. Br. (Asclepiadaceae) u
dozi 250 i 500 mg kg–1 testiran je na hepatoprotektivno djelovanje na o{te}enje jetre mu`-
jaka Wistar {takora inducirano tetraklormetanom, 2 mL kg–1 dva puta tjedno. Za{titni
u~inak ekstrakta biljke C. gigantea uspore|ivan je sa standarnim lijekom silimarinom. Eva-
luirani su razli~iti biokemijski parametri kao {to su aspartat amino transferaza (AST),
alanin amino transferaza (ALT), glutation (GSH), lipidni peroksidi (LPO), superoksid-
dismutaza (SOD), glutation peroksidaze (GPx) i katalaza (CAT). Rezultati ukazuju da eks-
trakt biljke C. gigantea zna~ajno smanjuje koncentracije AST, ALT (p < 0.001) i lipidnih
peroksida (p < 0.01). Koncentracije antioksidativnih parametara GSH, GPx, SOD i kata-
laze bile su zna~ajno povi{ene u usporedbi s njihovim koncentracijama u skupinama koje
nisu tretirane ekstraktom biljke C. gigantea.
Klju~ne rije~i: Calotropis gigantea (Asclepiadaceae), hepatoprotektivno djelovanje, enzimi seruma, anti-
oksidansi
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